A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
Recruiting · NCT07080021 · Registry updated 2025-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer | Borderline Resectable Pancreatic Adenocarcinoma; Resectable Pancreatic Adenocarcinoma | Recruiting | Not stated | 2025-07-29 | NCT07080021 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ruijin Hospital | Shanghai | China | 21 |
| Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine | Shanghai | China | 3 |